Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.
J. Clin. Invest. M K Cavaghan, et al. 100:530
doi:10.1172/JCI119562 [Go to this article.]

Problems with a PDF?